Author: Mehata, Abhishesh Kumar; Viswanadh, Matte Kasi; Priya, Vishnu; , Vikas; Muthu, Madaswamy S
Title: Harnessing immunological targets for COVID-19 immunotherapy Cord-id: 872ezo1e Document date: 2021_8_9
ID: 872ezo1e
Snippet: COVID-19 is an infectious and highly contagious disease caused by SARS-CoV-2. The immunotherapy strategy has a great potential to develop a permanent cure against COVID-19. Innate immune cells are in constant motion to scan molecular alteration to cells led by microbial infections throughout the body and helps in clearing invading viruses. Harnessing immunological targets for removing viral infection, generally based on the principle of enhancing the T-cell and protective immune responses. Curre
Document: COVID-19 is an infectious and highly contagious disease caused by SARS-CoV-2. The immunotherapy strategy has a great potential to develop a permanent cure against COVID-19. Innate immune cells are in constant motion to scan molecular alteration to cells led by microbial infections throughout the body and helps in clearing invading viruses. Harnessing immunological targets for removing viral infection, generally based on the principle of enhancing the T-cell and protective immune responses. Currently-approved COVID-19 vaccines are mRNA encapsulated in liposomes that stimulate the host immune system to produce antibodies. Given the vital role of innate immunity, harnessing these immune responses opens up new hope for the generation of long-lasting and protective immunity against COVID-19.
Search related documents:
Co phrase search for related documents- adaptive immune response and live virus vaccine: 1
- adaptive immune response and long genome: 1
- adaptive immune response and long term protective immunity: 1
- adaptive immune response and lopinavir ritonavir: 1
- adaptive immune response and low neutrophil: 1
- adaptive immune response and lung inflammation: 1, 2, 3, 4
- adaptive immune response and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9
- adaptive immune response and lung tissue: 1, 2, 3, 4, 5, 6, 7
- adaptive immune response and lymphocyte count: 1
- adaptive immune response and lymphoid cell: 1, 2
- adaptive immunity and live virus: 1, 2, 3, 4, 5, 6, 7, 8
- adaptive immunity and live virus vaccine: 1, 2
- adaptive immunity and long term protective immunity: 1, 2, 3, 4, 5, 6
- adaptive immunity and lopinavir ritonavir: 1, 2
- adaptive immunity and lung inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- adaptive immunity and lung injury: 1, 2, 3, 4, 5, 6, 7
- adaptive immunity and lung parenchyma: 1
- adaptive immunity and lung tissue: 1, 2, 3, 4, 5, 6, 7
- adaptive immunity and lymphocyte count: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date